title: Myocardial injection of apelin-overexpressing bone marrow cells improves cardiac repair via upregulation of Sirt3 after myocardial infarction.
abstract: Our previous study shows that treatment with apelin increases bone marrow cells (BMCs) recruitment and promotes cardiac repair after myocardial infarction (MI). The objective of this study was to investigate whether overexpression of apelin in BMCs improved cell therapy and accelerated cardiac repair and functional recovery in post-MI mice. Mouse myocardial infarction was achieved by coronary artery ligation and BMCs overexpressing apelin (apelin-BMCs) or GFP (GFP-BMCs) were injected into ischemic area immediately after surgery. In vitro, exposure of cultured BMCs to apelin led to a gradual increase in SDF-1á and CXCR4 expression. Intramyocardial delivery of apelin-BMCs in post-MI mice resulted in a significant increase number of APJ⁺/c-kit⁺/Sca1⁺ cells in the injected area compared to GFP-BMCs treated post-MI mice. Treatment with apelin-BMCs increased expression of VEGF, Ang-1 and Tie-2 in post-MI mice. Apelin-BMCs treatment also significantly increased angiogenesis and attenuated cardiac fibrosis formation in post-MI mice. Most importantly, treatment with apelin-BMCs significantly improved left ventricular (LV) systolic function in post-MI mice. Mechanistically, Apelin-BMCs treatment led to a significant increase in Sirtuin3 (Sirt3) expression and reduction of reactive oxygen species (ROS) formation. Treatment of cultured BMCs with apelin also increased Notch3 expression and Akt phosphorylation. Apelin treatment further attenuated stress-induced apoptosis whereas knockout of Sirt3 abolished anti-apoptotic effect of apelin in cultured BMCs. Moreover, knockout of Sirt3 significantly attenuated apelin-BMCs-induced VEGF expression and angiogenesis in post-MI mice. Knockout of Sirt3 further blunted apelin-BMCs-mediated improvement of cardiac repair and systolic functional recovery in post-MI mice. These data suggest that apelin improves BMCs therapy on cardiac repair and systolic function in post-MI mice. Upregulation of Sirt3 may contribute to the protective effect of apelin-BMCs therapy.
authors.affiliation: Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi, United States of America.
authors.forename: Lanfang
authors.initials: L
authors.lastname: Li
authors.forename: Heng
authors.initials: H
authors.lastname: Zeng
authors.forename: Xuwei
authors.initials: X
authors.lastname: Hou
authors.forename: Xiaochen
authors.initials: X
authors.lastname: He
authors.forename: Jian-Xiong
authors.initials: JX
authors.lastname: Chen
mesh_terms: D054392:Adipokines; D042501:Angiogenic Proteins / Q000378:metabolism; D000818:Animals; D000073861:Apelin; D001854:Bone Marrow Cells / Q000378:metabolism; D016026:Bone Marrow Transplantation; D006332:Cardiomegaly / Q000517:prevention & control; D002478:Cells, Cultured; D003331:Coronary Vessels / Q000503:physiopathology; D004790:Enzyme Induction; D005355:Fibrosis; D036341:Intercellular Signaling Peptides and Proteins / Q000378:metabolism*; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D009200:Myocardial Contraction; D009203:Myocardial Infarction / Q000201:enzymology / Q000503:physiopathology / Q000628:therapy*; D009206:Myocardium / Q000201:enzymology* / Q000473:pathology; D018919:Neovascularization, Physiologic; D017382:Reactive Oxygen Species / Q000378:metabolism; D012038:Regeneration; D056566:Sirtuin 3 / Q000378:metabolism*; D015854:Up-Regulation
chemical_list: D054392:Adipokines; D042501:Angiogenic Proteins; D000073861:Apelin; C402826:Apln protein, mouse; D036341:Intercellular Signaling Peptides and Proteins; D017382:Reactive Oxygen Species; C525046:Sirt3 protein, mouse; D056566:Sirtuin 3
references.citation: Circ Res. 2007 Mar 30;100(6):894-903
references.pmid: 17332431
references.citation: Blood. 2005 Jan 1;105(1):199-206
references.pmid: 15345590
references.citation: Dev Biol. 2006 Oct 1;298(1):188-200
references.pmid: 16876154
references.citation: Circ Res. 2011 Feb 18;108(4):478-89
references.pmid: 21233455
references.citation: Am J Physiol Heart Circ Physiol. 2012 Sep 1;303(5):H605-18
references.pmid: 22752632
references.citation: Peptides. 2009 Jun;30(6):1144-52
references.pmid: 19463748
references.citation: Am J Physiol Heart Circ Physiol. 2011 Jun;300(6):H2308-15
references.pmid: 21378145
references.citation: J Clin Invest. 2009 Sep;119(9):2758-71
references.pmid: 19652361
references.citation: Dev Cell. 2007 Mar;12(3):391-402
references.pmid: 17336905
references.citation: Am J Physiol Heart Circ Physiol. 2011 Jun;300(6):H2261-71
references.pmid: 21421825
references.citation: Basic Res Cardiol. 2012 Jul;107(4):273
references.pmid: 22622703
references.citation: J Clin Invest. 1999 May;103(9):1231-6
references.pmid: 10225965
references.citation: Eur Heart J. 2012 Aug;33(15):1911-9
references.pmid: 22173911
references.citation: Genomics. 2005 Feb;85(2):258-63
references.pmid: 15676284
references.citation: Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2547-57
references.pmid: 18408125
references.citation: J Biol Chem. 2007 Mar 2;282(9):6823-32
references.pmid: 17197703
references.citation: Mol Cell Biochem. 2004 Sep;264(1-2):63-74
references.pmid: 15544036
references.citation: Circulation. 2003 Nov 4;108(18):2212-8
references.pmid: 14557356
references.citation: Regul Pept. 2008 Feb 7;146(1-3):271-7
references.pmid: 18022257
references.citation: Am J Physiol Heart Circ Physiol. 2011 Dec;301(6):H2191-7
references.pmid: 21984547
references.citation: Folia Histochem Cytobiol. 2005;43(4):229-32
references.pmid: 16382890
references.citation: Cardiovasc Res. 2010 Nov 1;88(2):250-6
references.pmid: 20685942
references.citation: Stem Cell Res. 2012 May;8(3):357-67
references.pmid: 22289418
references.citation: Cell Transplant. 2010;19(8):949-58
references.pmid: 20447346
references.citation: PLoS One. 2012;7(4):e35905
references.pmid: 22558265
references.citation: Arterioscler Thromb Vasc Biol. 2002 Feb 1;22(2):249-55
references.pmid: 11834524
references.citation: Autophagy. 2011 Apr;7(4):432-3
references.pmid: 21187719
references.citation: Clin Exp Pharmacol Physiol. 2010 May;37(5-6):551-6
references.pmid: 20529094
references.citation: Exp Gerontol. 2003 Oct;38(10):1065-70
references.pmid: 14580859
references.citation: J Biol Chem. 2010 Jan 29;285(5):3133-44
references.pmid: 19940131
references.citation: Mol Cell Biol. 2008 Oct;28(20):6384-401
references.pmid: 18710944
references.citation: J Mol Cell Cardiol. 2008 Oct;45(4):530-44
references.pmid: 18755197
references.citation: Basic Res Cardiol. 2007 Nov;102(6):518-28
references.pmid: 17694254
references.citation: Aging (Albany NY). 2009 Aug 15;1(9):771-83
references.pmid: 20157566
references.citation: Nat Med. 2003 Sep;9(9):1195-201
references.pmid: 12910262
references.citation: Diabetes. 2008 Dec;57(12):3335-43
references.pmid: 18835934
references.citation: Circ Res. 2012 Aug 17;111(5):585-98
references.pmid: 22753078
references.citation: J Mol Cell Cardiol. 2012 Mar;52(3):520-5
references.pmid: 22119802
references.citation: Cell Transplant. 2009;18(12):1311-8
references.pmid: 19785937
references.citation: J Am Coll Cardiol. 2004 Oct 19;44(8):1690-9
references.pmid: 15489105